SCHAFFER DAVID 13D and 13G filings for 4D Molecular Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:32 pm Sale |
2021-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
SCHAFFER DAVID | 901,215 2.800% |
-1,098,785 (-54.94%) |
Filing |
| 2021-02-12 9:30 pm Purchase |
2020-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
SCHAFFER DAVID | 2,000,000 7.500% |
2,000,000 (New Position) |
Filing |